Last 12 months
Inside the activity.
21 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 11 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 8 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 09, 2018 Filed Aug 10, 2018 16:30 UTC |
Fishman KalmanCHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 1,682 | $7.50 | $12,615.00 |
DisclosureSEC source: 0001415889-18-001256 · form4-08102018_010822.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 933,817 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 16:27 UTC |
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 1,682 | $7.50 | $12,615.00 |
DisclosureSEC source: 0001415889-18-001254 · form4-08102018_010807.xml · nonDerivative · entry 2 Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 933,817 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 16:24 UTC |
Golin RichardEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 1,682 | $7.50 | $12,615.00 |
DisclosureSEC source: 0001415889-18-001252 · form4-08102018_010844.xml · nonDerivative · entry 2 Golin Richard · CIK 0001670070 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 933,817 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 20:22 UTC |
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 2,803 | $7.50 | $21,022.50 |
DisclosureSEC source: 0001415889-18-001250 · form4-08102018_010829.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,543,046 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 20:17 UTC |
Levine ArthurCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 161 | $7.50 | $1,207.50 |
DisclosureSEC source: 0001415889-18-001248 · form4-08102018_010853.xml · nonDerivative · entry 2 Levine Arthur · CIK 0001351380 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,589 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 08, 2018 Filed Aug 10, 2018 16:30 UTC |
Fishman KalmanCHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 2,020 | $7.50 | $15,150.00 |
DisclosureSEC source: 0001415889-18-001256 · form4-08102018_010822.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 935,499 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 08, 2018 Filed Aug 10, 2018 16:27 UTC |
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 2,020 | $7.50 | $15,150.00 |
DisclosureSEC source: 0001415889-18-001254 · form4-08102018_010807.xml · nonDerivative · entry 1 Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 935,499 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 08, 2018 Filed Aug 10, 2018 16:24 UTC |
Golin RichardEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 2,020 | $7.50 | $15,150.00 |
DisclosureSEC source: 0001415889-18-001252 · form4-08102018_010844.xml · nonDerivative · entry 1 Golin Richard · CIK 0001670070 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 935,499 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 08, 2018 Filed Aug 10, 2018 20:22 UTC |
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 3,367 | $7.50 | $25,252.50 |
DisclosureSEC source: 0001415889-18-001250 · form4-08102018_010829.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,545,849 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 08, 2018 Filed Aug 10, 2018 20:17 UTC |
Levine ArthurCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 192 | $7.50 | $1,440.00 |
DisclosureSEC source: 0001415889-18-001248 · form4-08102018_010853.xml · nonDerivative · entry 1 Levine Arthur · CIK 0001351380 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,750 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 15:40 UTC |
Fishman KalmanCHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 210 | $7.50 | $1,575.00 |
DisclosureSEC source: 0001415889-18-001217 · form4-08062018_120855.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937,519 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 15:44 UTC |
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 210 | $7.50 | $1,575.00 |
DisclosureSEC source: 0001415889-18-001219 · form4-08062018_120831.xml · nonDerivative · entry 1 Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937,519 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 15:53 UTC |
Golin RichardEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 210 | $7.50 | $1,575.00 |
DisclosureSEC source: 0001415889-18-001221 · form4-08062018_120824.xml · nonDerivative · entry 1 Golin Richard · CIK 0001670070 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937,519 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 19:56 UTC |
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 350 | $7.50 | $2,625.00 |
DisclosureSEC source: 0001415889-18-001223 · form4-08062018_120850.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,549,216 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| August 02, 2018 Filed Aug 6, 2018 19:37 UTC |
Levine ArthurCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 20 | $7.50 | $150.00 |
DisclosureSEC source: 0001415889-18-001215 · form4-08062018_120854.xml · nonDerivative · entry 1 Levine Arthur · CIK 0001351380 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,942 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 16:54 UTC |
Fishman KalmanCHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 452 | $7.50 | $3,390.00 |
DisclosureSEC source: 0001415889-18-001053 · form4-06282018_010659.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937,729 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 17:00 UTC |
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 452 | $7.50 | $3,390.00 |
DisclosureSEC source: 0001415889-18-001057 · form4-06282018_010647.xml · nonDerivative · entry 1 Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937,729 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 16:56 UTC |
Golin RichardEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 452 | $7.50 | $3,390.00 |
DisclosureSEC source: 0001415889-18-001055 · form4-06282018_010643.xml · nonDerivative · entry 1 Golin Richard · CIK 0001670070 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937,729 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 21:03 UTC |
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 754 | $7.50 | $5,655.00 |
DisclosureSEC source: 0001415889-18-001059 · form4-06282018_020631.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,549,566 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| June 26, 2018 Filed Jun 28, 2018 20:50 UTC |
Levine ArthurCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 44 | $7.50 | $330.00 |
DisclosureSEC source: 0001415889-18-001051 · form4-06282018_010643.xml · nonDerivative · entry 1 Levine Arthur · CIK 0001351380 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,962 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. Read SEC document |
| June 25, 2018 Filed Jun 25, 2018 19:18 UTC |
Fishman KalmanCHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 6,530 | $7.52 | $49,105.60 |
DisclosureSEC source: 0001415889-18-001021 · form4-06252018_040658.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 938,181 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F4 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.57. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 25, 2018 Filed Jun 25, 2018 19:18 UTC |
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 6,530 | $7.52 | $49,105.60 |
DisclosureSEC source: 0001415889-18-001022 · form4-06252018_040640.xml · nonDerivative · entry 2 Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 938,181 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F4 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.57. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 25, 2018 Filed Jun 25, 2018 19:19 UTC |
Golin RichardEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 6,530 | $7.52 | $49,105.60 |
DisclosureSEC source: 0001415889-18-001023 · form4-06252018_040622.xml · nonDerivative · entry 2 Golin Richard · CIK 0001670070 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 938,181 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F4 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.57. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 25, 2018 Filed Jun 25, 2018 23:20 UTC |
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 10,854 | $7.52 | $81,622.08 |
DisclosureSEC source: 0001415889-18-001024 · form4-06252018_040605.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,550,320 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F4 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.57. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 25, 2018 Filed Jun 25, 2018 23:17 UTC |
Levine ArthurCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 611 | $7.52 | $4,594.72 |
DisclosureSEC source: 0001415889-18-001020 · form4-06252018_040610.xml · nonDerivative · entry 2 Levine Arthur · CIK 0001351380 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,006 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F4 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.57. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 21, 2018 Filed Jun 25, 2018 19:18 UTC |
Fishman KalmanCHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 2,919 | $7.52 | $21,950.88 |
DisclosureSEC source: 0001415889-18-001021 · form4-06252018_040658.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 944,711 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.60. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 21, 2018 Filed Jun 25, 2018 19:18 UTC |
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 2,919 | $7.52 | $21,950.88 |
DisclosureSEC source: 0001415889-18-001022 · form4-06252018_040640.xml · nonDerivative · entry 1 Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 944,711 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.60. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 21, 2018 Filed Jun 25, 2018 19:19 UTC |
Golin RichardEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 2,919 | $7.52 | $21,950.88 |
DisclosureSEC source: 0001415889-18-001023 · form4-06252018_040622.xml · nonDerivative · entry 1 Golin Richard · CIK 0001670070 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 944,711 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.60. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 21, 2018 Filed Jun 25, 2018 23:20 UTC |
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 4,865 | $7.52 | $36,584.80 |
DisclosureSEC source: 0001415889-18-001024 · form4-06252018_040605.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,561,174 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.60. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 21, 2018 Filed Jun 25, 2018 23:17 UTC |
Levine ArthurCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 278 | $7.52 | $2,090.56 |
DisclosureSEC source: 0001415889-18-001020 · form4-06252018_040610.xml · nonDerivative · entry 1 Levine Arthur · CIK 0001351380 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,617 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.60. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 21, 2018 Filed Apr 27, 2021 15:08 UTC |
McCall William HDirector
|
OtherCommon Stock | 195,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-002126 · form5-04272021_120452.xml · nonDerivative · entry 4 McCall William H · CIK 0001670233 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Investors Capital Alliance, LLC Disclosed balance after: 228,620 F1 · shares: Represents distribution of shares owned by an investor but held in an investment fund. Transaction is being reported late as a result of administrative oversight. F2 · ownership.nature: Represents shares of Common Stock of Sensus Healthcare, Inc. held by Investors Capital Alliance, LLC, for which the reporting person serves as managing partner and over which the reporting person has voting and dispositive power. Read SEC document |
| June 20, 2018 Filed Jun 20, 2018 18:29 UTC |
Fishman KalmanCHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 4,767 | $7.52 | $35,847.84 |
DisclosureSEC source: 0001415889-18-000980 · form4-06202018_030600.xml · nonDerivative · entry 3 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 947,630 F5 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F6 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.65. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 20, 2018 Filed Jun 20, 2018 18:27 UTC |
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 4,767 | $7.52 | $35,847.84 |
DisclosureSEC source: 0001415889-18-000979 · form4-06202018_030659.xml · nonDerivative · entry 3 Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 947,630 F5 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F6 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.65. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 20, 2018 Filed Jun 20, 2018 18:25 UTC |
Golin RichardEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 4,767 | $7.52 | $35,847.84 |
DisclosureSEC source: 0001415889-18-000978 · form4-06202018_030607.xml · nonDerivative · entry 3 Golin Richard · CIK 0001670070 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 947,630 F5 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F6 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.65. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 20, 2018 Filed Jun 20, 2018 22:22 UTC |
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 7,945 | $7.52 | $59,746.40 |
DisclosureSEC source: 0001415889-18-000977 · form4-06202018_030637.xml · nonDerivative · entry 3 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,566,039 F5 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F6 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.65. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 20, 2018 Filed Jun 20, 2018 22:20 UTC |
Levine ArthurCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 454 | $7.52 | $3,414.08 |
DisclosureSEC source: 0001415889-18-000976 · form4-06202018_030607.xml · nonDerivative · entry 3 Levine Arthur · CIK 0001351380 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,895 F5 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F6 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.65. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 19, 2018 Filed Jun 20, 2018 18:29 UTC |
Fishman KalmanCHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 2,626 | $7.57 | $19,878.82 |
DisclosureSEC source: 0001415889-18-000980 · form4-06202018_030600.xml · nonDerivative · entry 2 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 952,397 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F4 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.64. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 19, 2018 Filed Jun 20, 2018 18:27 UTC |
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 2,626 | $7.57 | $19,878.82 |
DisclosureSEC source: 0001415889-18-000979 · form4-06202018_030659.xml · nonDerivative · entry 2 Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 952,397 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F4 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.64. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 19, 2018 Filed Jun 20, 2018 18:25 UTC |
Golin RichardEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 2,626 | $7.57 | $19,878.82 |
DisclosureSEC source: 0001415889-18-000978 · form4-06202018_030607.xml · nonDerivative · entry 2 Golin Richard · CIK 0001670070 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 952,397 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F4 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.64. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 19, 2018 Filed Jun 20, 2018 22:22 UTC |
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 4,365 | $7.57 | $33,043.05 |
DisclosureSEC source: 0001415889-18-000977 · form4-06202018_030637.xml · nonDerivative · entry 2 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,573,984 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F4 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.64. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 19, 2018 Filed Jun 20, 2018 22:20 UTC |
Levine ArthurCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 247 | $7.57 | $1,869.79 |
DisclosureSEC source: 0001415889-18-000976 · form4-06202018_030607.xml · nonDerivative · entry 2 Levine Arthur · CIK 0001351380 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,349 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F4 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.64. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 18, 2018 Filed Jun 20, 2018 18:29 UTC |
Fishman KalmanCHIEF TECHNOLOGY OFFICER
|
SaleCommon Stock | 5,626 | $7.52 | $42,307.52 |
DisclosureSEC source: 0001415889-18-000980 · form4-06202018_030600.xml · nonDerivative · entry 1 Fishman Kalman · CIK 0001670242 · CHIEF TECHNOLOGY OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 955,023 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.57. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 18, 2018 Filed Jun 20, 2018 18:27 UTC |
Cohen Stephen BradEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 5,626 | $7.52 | $42,307.52 |
DisclosureSEC source: 0001415889-18-000979 · form4-06202018_030659.xml · nonDerivative · entry 1 Cohen Stephen Brad · CIK 0001670284 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 955,023 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.57. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 18, 2018 Filed Jun 20, 2018 18:25 UTC |
Golin RichardEXECUTIVE VICE PRESIDENT
|
SaleCommon Stock | 5,626 | $7.52 | $42,307.52 |
DisclosureSEC source: 0001415889-18-000978 · form4-06202018_030607.xml · nonDerivative · entry 1 Golin Richard · CIK 0001670070 · EXECUTIVE VICE PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 955,023 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.57. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 18, 2018 Filed Jun 20, 2018 22:22 UTC |
Sardano Joseph CDirector · CHIEF EXECUTIVE OFFICER
|
SaleCommon Stock | 9,352 | $7.52 | $70,327.04 |
DisclosureSEC source: 0001415889-18-000977 · form4-06202018_030637.xml · nonDerivative · entry 1 Sardano Joseph C · CIK 0001300111 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,578,349 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.57. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 18, 2018 Filed Jun 20, 2018 22:20 UTC |
Levine ArthurCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 527 | $7.52 | $3,963.04 |
DisclosureSEC source: 0001415889-18-000976 · form4-06202018_030607.xml · nonDerivative · entry 1 Levine Arthur · CIK 0001351380 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,596 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November 2017. F2 · price: The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.57. The reporting person undertakes to provide to Sensus Healthcare, Inc., any security holder of Sensus Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4. Read SEC document |
| June 02, 2018 Filed Jun 5, 2018 17:14 UTC |
Levine ArthurChief Financial Officer
|
Tax withholdingCommon Stock | 12,670 | $6.33 | $80,201.10 |
DisclosureSEC source: 0001615774-18-004847 · s110658_form4.xml · nonDerivative · entry 1 Levine Arthur · CIK 0001351380 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,123 F1 · shares: Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock. Read SEC document |
| June 02, 2018 Filed Jun 5, 2018 17:12 UTC |
Sardano MichaelGeneral Counsel
|
Tax withholdingCommon Stock | 1,482 | $6.33 | $9,381.06 |
DisclosureSEC source: 0001615774-18-004845 · s110657_form4.xml · nonDerivative · entry 1 Sardano Michael · CIK 0001720602 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,885 F1 · shares: Represents shares withheld to pay the reporting person's withholding tax obligation arising solely in connection with the vesting of restricted stock. Read SEC document |
| May 19, 2018 Filed Apr 27, 2021 15:08 UTC |
McCall William HDirector
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-002126 · form5-04272021_120452.xml · nonDerivative · entry 3 McCall William H · CIK 0001670233 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F3 · shares: Transaction is being reported late as a result of administrative oversight. Read SEC document |
| May 15, 2018 Filed Apr 27, 2021 15:08 UTC |
McCall William HDirector
|
OtherCommon Stock | 73,473 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-002126 · form5-04272021_120452.xml · nonDerivative · entry 2 McCall William H · CIK 0001670233 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Investors Capital Alliance, LLC Disclosed balance after: 423,620 F1 · shares: Represents distribution of shares owned by an investor but held in an investment fund. Transaction is being reported late as a result of administrative oversight. F2 · ownership.nature: Represents shares of Common Stock of Sensus Healthcare, Inc. held by Investors Capital Alliance, LLC, for which the reporting person serves as managing partner and over which the reporting person has voting and dispositive power. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.